18 November 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics investigates long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease.
The efficacy and safety of certolizumab pegol (CZP) in moderate-to-severe Crohn's disease were de
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors